ITNS News Thursday, June 5, 2014 9:23:54 PM $ITNS
Post# of 109
Posted On: 06/05/2014 10:23:31 PM
ITNS News Thursday, June 5, 2014 9:23:54 PM $ITNS
Itonis Pharmaceuticals Receives NDC Number From FDA to Enable Production and Marketing of Emesyl(R) Product
Marketwire - Thu Jun 05, 1:47AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that the U.S. Food & Drug Administration (FDA) has published final approval of the Company's National Drug Code (NDC) number (59067-001) for its Emesyl(R) over-the-counter homeopathic product for nausea relief.
Itonis, Inc. Signs First Retail Merchant for MyECheck's Point of Sale Mobile Payment Application
Marketwire - Thu May 08, 8:30AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a letter of intent with Valley Organics Inc. for retail use of MyECheck's patented mobile payment application that will facilitate point of purchase transactions for medical marijuana.
Itonis, Inc. Readies Preliminary Packaging Design for Project "Cloud9" Cannabinoid-Based Product
Marketwire - Thu Apr 24, 8:05AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today unveiled its preliminary packaging design for its cannabinoid-based product that had been code named Project "Cloud9." For an available image of the packaging design, please use this link: http://itonisholdings.com/wp-content/uploads/...00x801.jpg.
Itonis Pharmaceuticals in Final Steps of NDC Registration With FDA for Emesyl Product
Marketwire - Tue Apr 22, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to share an update from its manufacturer that the Company's Emesyl(TM) anti-nausea product is in its final steps of completing the NDC registration with the Food and Drug Administration ("FDA"
, and is being readied for the first production run. While the process has taken longer than expected, the Company is pleased with recent progress to deliver Emesyl(TM) to market.
Itonis, Inc. Signed Exploratory Analysis Trial for Cloud9 Project With Valley Organics Inc.
Marketwire - Wed Apr 16, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed an agreement with Valley Organics Inc. to start a 30-day "Exploratory Analysis Trial" for the Company's cannabinoid-based product that is presently named as its Cloud9 project.
Itonis Inc. to Market its MyECheck Proprietary Mobile App to Marijuana Dispensary Market
ACCESSWIRE - Mon Apr 14, 11:32PM CDT
Itonis Inc. (OTC: ITNS) plans to market its MyECheck proprietary mobile app to the massively exploding marijuana dispensary market in order to facilitate cash-free point of sale transactions to gain transactional fee revenues. The proprietary mobile app is coded and designed to work like an electronic check, allowing monies to be transferred safely and securely between the transacting parties. Due to existing banking limitations, marijuana dispensaries are conducting all their financial transactions strictly on a "cash only" basis, even in states where the sale of marijuana is legal. The MyECheck mobile app will allow consumers and dispensaries the security and convenience of a non-cash alternative to complete their transactions.
Itonis Inc. Joins the National Cannabis Industry Association - Announces Development of Cannabinoid-based Product called "Cloud9"
ACCESSWIRE - Wed Apr 09, 11:44PM CDT
Itonis Inc. (OTC: ITNS) has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc. The company is also in the final phase of its research and development of a cannabinoid-based product presently named "Cloud9™."
Itonis, Inc. to Profit From Transactional Revenues by Marketing Its Licensed MyECheck Mobile App to Marijuana Dispensary Market
Marketwire - Tue Apr 08, 12:27PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced its plans to market its MyECheck proprietary mobile app to the massively exploding marijuana dispensary market in order to facilitate cash-free point of sale transactions to gain transactional fee revenues.
Itonis, Inc. Developing Cannabinoid-Based "Cloud9" Product
Marketwire - Thu Apr 03, 8:31AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it is in the final phase of its research and development of a cannabinoid-based product presently named "Cloud9(TM)."
COREwafer Industries Inc.'s Stock Volume Soars amid Lawsuits and Hidden Debt
ACCESSWIRE - Tue Apr 01, 9:02AM CDT
COREwafer Industries Inc.'s (OCTPINK: WAFR) share volume soared Mar. 31, with 92,841,276 shares changing hands, nearly double its three-month average volume of 47,097,800 shares.
Itonis, Inc. Joins the National Cannabis Industry Association to Advance Into the Medical Marijuana Products and Services Sector
Marketwire - Tue Apr 01, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc.
Itonis Inc. Signs Licensing Agreement with MyECheck Inc. for Medical Marijuana Point of Purchase App
ACCESSWIRE - Tue Apr 01, 12:45AM CDT
Itonis Inc. (OTC: ITNS) has signed a Licensing Agreement with MyECheck, Inc. that opens the gates for Itonis to possibly become a leading player in the blossoming medical marijuana industry. In the licensing agreement, Itonis will acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license. The company believes there is a significant revenue opportunity in addressing the demand regarding medical marijuana and the point of sales from medical suppliers.
Itonis, Inc. OTCpink ITNS today announced that it has signed a Licensing Agreement with MyECheck,OTCpink MYEC
M2 - Fri Mar 28, 12:50PM CDT
March 28, 2014 Vancouver (321gostocks) -- Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
Marketwire - Fri Mar 28, 10:14AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Wed Mar 26, 10:29AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:
Arotech Corporation Announces More than $2M in Orders; DirectView Holdings Plans to Open a Colorado Office
ACCESSWIRE - Tue Mar 25, 11:26PM CDT
Arotech Corporation (NASDAQ: ARTX) - For an in-depth report on Arotech Corporation follow: www.BullTrends.com/stockquote/ARTX
Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
Marketwire - Wed Mar 19, 10:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, and his team has completed their evaluation of the manufactured samples of Emesyl(TM), the company's over-the-counter homeopathic product for nausea relief.
Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Mon Mar 17, 2:29PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has entered into a Letter of Intent with MyECheck, Inc. to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales.
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.
Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products
Marketwire - Mon Dec 09, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce today the addition of Ernesto Barron to Dr. Hensley's product development team. Mr. Barron will serve as Itonis Phamaceuticals' Chief Scientific Officer and Director of Clinical Research.
Itonis Pharmaceuticals Receives NDC Number From FDA to Enable Production and Marketing of Emesyl(R) Product
Marketwire - Thu Jun 05, 1:47AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that the U.S. Food & Drug Administration (FDA) has published final approval of the Company's National Drug Code (NDC) number (59067-001) for its Emesyl(R) over-the-counter homeopathic product for nausea relief.
Itonis, Inc. Signs First Retail Merchant for MyECheck's Point of Sale Mobile Payment Application
Marketwire - Thu May 08, 8:30AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a letter of intent with Valley Organics Inc. for retail use of MyECheck's patented mobile payment application that will facilitate point of purchase transactions for medical marijuana.
Itonis, Inc. Readies Preliminary Packaging Design for Project "Cloud9" Cannabinoid-Based Product
Marketwire - Thu Apr 24, 8:05AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today unveiled its preliminary packaging design for its cannabinoid-based product that had been code named Project "Cloud9." For an available image of the packaging design, please use this link: http://itonisholdings.com/wp-content/uploads/...00x801.jpg.
Itonis Pharmaceuticals in Final Steps of NDC Registration With FDA for Emesyl Product
Marketwire - Tue Apr 22, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to share an update from its manufacturer that the Company's Emesyl(TM) anti-nausea product is in its final steps of completing the NDC registration with the Food and Drug Administration ("FDA"
, and is being readied for the first production run. While the process has taken longer than expected, the Company is pleased with recent progress to deliver Emesyl(TM) to market. Itonis, Inc. Signed Exploratory Analysis Trial for Cloud9 Project With Valley Organics Inc.
Marketwire - Wed Apr 16, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed an agreement with Valley Organics Inc. to start a 30-day "Exploratory Analysis Trial" for the Company's cannabinoid-based product that is presently named as its Cloud9 project.
Itonis Inc. to Market its MyECheck Proprietary Mobile App to Marijuana Dispensary Market
ACCESSWIRE - Mon Apr 14, 11:32PM CDT
Itonis Inc. (OTC: ITNS) plans to market its MyECheck proprietary mobile app to the massively exploding marijuana dispensary market in order to facilitate cash-free point of sale transactions to gain transactional fee revenues. The proprietary mobile app is coded and designed to work like an electronic check, allowing monies to be transferred safely and securely between the transacting parties. Due to existing banking limitations, marijuana dispensaries are conducting all their financial transactions strictly on a "cash only" basis, even in states where the sale of marijuana is legal. The MyECheck mobile app will allow consumers and dispensaries the security and convenience of a non-cash alternative to complete their transactions.
Itonis Inc. Joins the National Cannabis Industry Association - Announces Development of Cannabinoid-based Product called "Cloud9"
ACCESSWIRE - Wed Apr 09, 11:44PM CDT
Itonis Inc. (OTC: ITNS) has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc. The company is also in the final phase of its research and development of a cannabinoid-based product presently named "Cloud9™."
Itonis, Inc. to Profit From Transactional Revenues by Marketing Its Licensed MyECheck Mobile App to Marijuana Dispensary Market
Marketwire - Tue Apr 08, 12:27PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced its plans to market its MyECheck proprietary mobile app to the massively exploding marijuana dispensary market in order to facilitate cash-free point of sale transactions to gain transactional fee revenues.
Itonis, Inc. Developing Cannabinoid-Based "Cloud9" Product
Marketwire - Thu Apr 03, 8:31AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it is in the final phase of its research and development of a cannabinoid-based product presently named "Cloud9(TM)."
COREwafer Industries Inc.'s Stock Volume Soars amid Lawsuits and Hidden Debt
ACCESSWIRE - Tue Apr 01, 9:02AM CDT
COREwafer Industries Inc.'s (OCTPINK: WAFR) share volume soared Mar. 31, with 92,841,276 shares changing hands, nearly double its three-month average volume of 47,097,800 shares.
Itonis, Inc. Joins the National Cannabis Industry Association to Advance Into the Medical Marijuana Products and Services Sector
Marketwire - Tue Apr 01, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc.
Itonis Inc. Signs Licensing Agreement with MyECheck Inc. for Medical Marijuana Point of Purchase App
ACCESSWIRE - Tue Apr 01, 12:45AM CDT
Itonis Inc. (OTC: ITNS) has signed a Licensing Agreement with MyECheck, Inc. that opens the gates for Itonis to possibly become a leading player in the blossoming medical marijuana industry. In the licensing agreement, Itonis will acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license. The company believes there is a significant revenue opportunity in addressing the demand regarding medical marijuana and the point of sales from medical suppliers.
Itonis, Inc. OTCpink ITNS today announced that it has signed a Licensing Agreement with MyECheck,OTCpink MYEC
M2 - Fri Mar 28, 12:50PM CDT
March 28, 2014 Vancouver (321gostocks) -- Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
Marketwire - Fri Mar 28, 10:14AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Wed Mar 26, 10:29AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:
Arotech Corporation Announces More than $2M in Orders; DirectView Holdings Plans to Open a Colorado Office
ACCESSWIRE - Tue Mar 25, 11:26PM CDT
Arotech Corporation (NASDAQ: ARTX) - For an in-depth report on Arotech Corporation follow: www.BullTrends.com/stockquote/ARTX
Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
Marketwire - Wed Mar 19, 10:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, and his team has completed their evaluation of the manufactured samples of Emesyl(TM), the company's over-the-counter homeopathic product for nausea relief.
Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Mon Mar 17, 2:29PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has entered into a Letter of Intent with MyECheck, Inc. to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales.
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.
Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products
Marketwire - Mon Dec 09, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce today the addition of Ernesto Barron to Dr. Hensley's product development team. Mr. Barron will serve as Itonis Phamaceuticals' Chief Scientific Officer and Director of Clinical Research.
(0)
(0)Itonis Inc. (ITNS) Stock Research Links
Scroll down for more posts ▼